As Fgf9 and Cacna2d3 both belong to the MAPK signaling pathway, it suggests that BPD-EXO may impair endothelial functions by dysregulating the MAPK signaling pathway. This evidence concerns the gene FGF9 and bronchopulmonary dysplasia.